The largest database of trusted experimental protocols

Bz h4c hybrid cell count software

Manufactured by Keyence
Sourced in Japan

The BZ-H4C/hybrid cell count software is a laboratory equipment product that provides automated cell counting functionality. It is designed to accurately and efficiently count cells in a variety of samples. The core function of this product is to perform cell enumeration tasks.

Automatically generated - may contain errors

2 protocols using bz h4c hybrid cell count software

1

RNA ISH Detection of CXCL13 in Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We assessed CXCL13 by RNA ISH (RNAscope 2.5 HD Reagent kit [RED]; Advanced Cell Diagnostics). FFPE tissue sections were deparaffinized in xylene and subsequently dehydrated in an ethanol series. Tissue sections were incubated in target retrieval reagent at 100°C for 15 minutes and were then treated with protease at 40°C for 30 minutes. Hybridization with Hs-CXCL13 (for human) or Mm-Cxcl13 (for mouse) probes at 40°C for 2 hours, and the amplifier and visualization (Fast RED) procedures, were performed in accordance with the manufacturer’s instructions. For multiplex detection using FFPE, an RNAscope Fluorescent Multiplex Reagent kit v2 (Advanced Cell Diagnostics) was used. Double staining was performed for CXCL13 and CD8, CXCL13 and CD4, and CXCL13 and CD21 (CR2). The target probes were Hs-CXCL13 (C1), Hs-CD4 (C2), Hs-CD8A (C2), and Hs-CR2 targeting 269-1303 of NM_001006658.3 (C2). CXCL13 was detected with Opal 690 (1:1000 dilution, PerkinElmer), and CD4, CD8, and CR2 were detected with Opal 570 (1:1500 dilution, PerkinElmer). Fluorescence images were captured using a fluorescence microscope BZ-X800E (KEYENCE), and the colocalization of CXCL13 with various immune cells was quantified using BZ-H4C/hybrid cell count software (KEYENCE).
+ Open protocol
+ Expand
2

Multiplex Analysis of CXCL13 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
We assessed CXCL13 by RNA in situ hybridization (ISH) (RNAscope ® 2.5 HD Reagent kit (RED), Advanced Cell Diagnostics, Hayward, CA, USA). FFPE tissue sections were deparaffinized in xylene and subsequently dehydrated in an ethanol series. Tissue sections were incubated in target retrieval reagent at 100°C for 15 minutes, and then treated with protease at 40°C for 30 minutes. Hybridization with Hs-CXCL13 (for human) or Mm-Cxcl13 (for mouse) probes at 40°C for 2 hours, and the amplifier and visualization (Fast RED) procedures were performed in accordance with the manufacturer's instructions. For multiplex detection using FFPE, an RNAscope ® Fluorescent Multiplex Reagent kit v2 (Advanced Cell Diagnostics) was used. Double staining was performed for CXCL13 and CD8, CXCL13 and CD4, and CXCL13 and CD21(CR2). The target probes and reagents used were listed in Supplemental Table S2. CXCL13 was detected with Opal 690, and CD4, CD8, and CR2 with Opal 570. Fluorescence images were captured using a fluorescence microscope BZ-X800E (KEYENCE, Osaka, Japan), and the colocalization of CXCL13 with various immune cells was quantified using BZ-H4C/hybrid cell count software (KEYENCE).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!